Eledon Pharmaceuticals ELDN
NASDAQ ELDN
$3.02 +0.09 (+3.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Eledon Pharmaceuticals (ELDN) Net Equity Issued and Repurchased (2013 - 2024)

Eledon Pharmaceuticals' (ELDN) quarterly Net Equity Issued and Repurchased came in at $4.0 million in Q3 2024, down 55.01% on a QoQ basis from $8.9 million in Q4 2020.

Analysis

Eledon Pharmaceuticals (ELDN) Net Equity Issued and Repurchased (2013 - 2024) Analysis & Trends

Eledon Pharmaceuticals (ELDN) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $4.0 million in Q3 2024.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $4.0 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $4.0 million (changed N/A YoY) and the FY2020 annual result came in at $9.0 million, down 6.99% from the prior year.
  • Net Equity Issued and Repurchased retreated to $4.0 million in Q3 2024, from $8.9 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $8.9 million in Q4 2020 to a low of $110000.0 in Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 141.90 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Eledon Pharmaceuticals 344.87 Mn 344.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 4.00 Mn
Dec 31, 2020 8.89 Mn
Mar 31, 2020 110,000.00
Jun 30, 2019 9.57 Mn
Mar 31, 2019 107,000.00
Dec 31, 2018 1,000.00
Sep 30, 2018 -1,000.00
Mar 31, 2018 7.49 Mn
Dec 31, 2017 750,000.00
Dec 31, 2013 15.49 Mn